AU2001254813A1 - Regulation of nf-at interacting protein nip 45 variant - Google Patents
Regulation of nf-at interacting protein nip 45 variantInfo
- Publication number
- AU2001254813A1 AU2001254813A1 AU2001254813A AU5481301A AU2001254813A1 AU 2001254813 A1 AU2001254813 A1 AU 2001254813A1 AU 2001254813 A AU2001254813 A AU 2001254813A AU 5481301 A AU5481301 A AU 5481301A AU 2001254813 A1 AU2001254813 A1 AU 2001254813A1
- Authority
- AU
- Australia
- Prior art keywords
- nip
- interacting protein
- variant
- regulation
- activation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 208000037976 chronic inflammation Diseases 0.000 abstract 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Dairy Products (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Disclosed are novel nucleic acid and amino acid sequences of NF-AT interacting protein NIP 45 variants. Reagents that bind to NIP45-variant gene products can be used to treat conditions involving inflammatory processes, such as allergy, asthma, autoimmune diseases, and other chronic inflammatory diseases where an over-activation or prolongation of the activation of the immune system causes damage to tissues.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19935600P | 2000-04-25 | 2000-04-25 | |
| US60199356 | 2000-04-25 | ||
| PCT/EP2001/004635 WO2001081574A2 (en) | 2000-04-25 | 2001-04-25 | Regulation of nf-at interacting protein nip 45 variant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001254813A1 true AU2001254813A1 (en) | 2001-11-07 |
Family
ID=22737188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001254813A Abandoned AU2001254813A1 (en) | 2000-04-25 | 2001-04-25 | Regulation of nf-at interacting protein nip 45 variant |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1280897B1 (en) |
| JP (1) | JP2003530883A (en) |
| AT (1) | ATE340261T1 (en) |
| AU (1) | AU2001254813A1 (en) |
| DE (1) | DE60123235T2 (en) |
| DK (1) | DK1280897T3 (en) |
| ES (1) | ES2272471T3 (en) |
| WO (1) | WO2001081574A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002214005A1 (en) * | 2000-10-10 | 2002-04-22 | Bayer Aktiengesellschaft | Regulation of nf-at interacting protein nip 45 like protein |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1225682A (en) * | 1996-04-23 | 1999-08-11 | 哈佛大学校长及研究员协会 | Method and compositions for regulating T cell subsets by modulating transcription facter activity |
| GB9722388D0 (en) * | 1997-10-24 | 1997-12-24 | Zeneca Ltd | NIP45 human homolog |
-
2001
- 2001-04-25 EP EP01927920A patent/EP1280897B1/en not_active Expired - Lifetime
- 2001-04-25 AU AU2001254813A patent/AU2001254813A1/en not_active Abandoned
- 2001-04-25 DK DK01927920T patent/DK1280897T3/en active
- 2001-04-25 WO PCT/EP2001/004635 patent/WO2001081574A2/en not_active Ceased
- 2001-04-25 ES ES01927920T patent/ES2272471T3/en not_active Expired - Lifetime
- 2001-04-25 AT AT01927920T patent/ATE340261T1/en not_active IP Right Cessation
- 2001-04-25 DE DE60123235T patent/DE60123235T2/en not_active Expired - Fee Related
- 2001-04-25 JP JP2001578645A patent/JP2003530883A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE60123235D1 (en) | 2006-11-02 |
| ES2272471T3 (en) | 2007-05-01 |
| ATE340261T1 (en) | 2006-10-15 |
| WO2001081574A3 (en) | 2002-04-18 |
| DE60123235T2 (en) | 2007-09-13 |
| EP1280897A2 (en) | 2003-02-05 |
| WO2001081574A2 (en) | 2001-11-01 |
| DK1280897T3 (en) | 2007-01-08 |
| JP2003530883A (en) | 2003-10-21 |
| EP1280897B1 (en) | 2006-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002365811A1 (en) | Methods for the selection and cloning of nucleic acid molecules free of unwanted nucleotide sequence alterations | |
| MXPA02012743A (en) | Il-17 molecules and uses thereof. | |
| WO2000069896A3 (en) | Molecular interactions in haematopoietic cells | |
| WO2004043407A3 (en) | Methods and products for treating staphylococcal infections | |
| EP1808180A3 (en) | Modified GP 100 and uses thereof | |
| WO2002014485A3 (en) | Kallikrein gene | |
| WO2001048209A3 (en) | Genes identified as required for proliferation of e. coli | |
| WO2000053776A3 (en) | Human kallikrein-like genes | |
| WO2002040668A3 (en) | Proteins and dna sequences underlying these proteins used for treating inflammations | |
| WO2003040181A3 (en) | Genes from the corynebacterium glutamicum coding for regulatory proteins | |
| WO2003046123A3 (en) | Mutated gene from corynebacterium glutamicum | |
| WO1998010076A3 (en) | Phospholipase d and dna sequences | |
| WO2001040313A3 (en) | Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof | |
| AU2001254813A1 (en) | Regulation of nf-at interacting protein nip 45 variant | |
| WO2002031512A3 (en) | Molecular interactions in hematopoietic cells | |
| WO2002030972A3 (en) | Regulation of nf-at interacting protein nip 45 like protein | |
| PL374550A1 (en) | Il-17 like molecules and uses thereof | |
| WO2001085935A3 (en) | Endothelial differentiation gene 6-like g protein coupled receptor | |
| WO2003002599A3 (en) | Immune-related proteins and the regulation of the same | |
| PT1322753E (en) | NEW REDUCTIONS OF 2,5-DICETO-L-GLUCONIC ACID AND METHODS OF USE | |
| WO2001039786A3 (en) | New uses of suppressive macrophage activation factors | |
| WO2009083968A8 (en) | Novel protein | |
| WO2000069898A3 (en) | Molecular interactions in allergy cells | |
| WO2001077348A3 (en) | Ketogulonigenium endogenous plasmids | |
| AU2002323612A1 (en) | Novel clark protein and nucleic acid molecules and uses therefor |